SATO VICKI L sold VIR
February 24, 2026 · Form 4 insider transaction
SATO VICKI L sold 200 shares of Vir Biotechnology, Inc. at $10.26 per share, a transaction worth $2.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$10.26
Total value
$2.1K
InsiderSATO VICKI L
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after1,144,391
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.